RVL Pharmaceuticals (RVLP) Key Ratios
$0.00
$0.00
(14.29%)
As on 22-Dec-2023 09:30EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -6.50 | -2.25 | 5.64 | -44.12 | -32.41 |
| EBIT | 24.69 | 48.76 | 32.45 | -344.43 | -243.64 |
| Net Profit | -105.73 | -97.33 | -20.81 | 16.00 | -224.08 |
| EPS | -105.73 | -67.43 | 4.75 | 20.67 | -- |
| Book Value | -- | -- | -40.07 | -36.39 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| -258.10 | -154.05 | -117.02 | -91.87 | -460.03 |
| Net Margin
| -90.29 | -90.29 | -143.19 | -90.29 | -- |
| Return on equity
| -87.79 | -79.87 | -202.51 | -80.88 | -97.13 |
| Return on Capital
| -35.79 | -35.03 | -- | -44.38 | -37.67 |
| Return on Assets
| -30.44 | -29.48 | -45.94 | -37.84 | -32.14 |
| Debt to Equity (x)
| -- | -- | 0.00 | 1.13 | 0.62 |
The underlying data is unavailable.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
